Osiris Therapeutics appoints Hunt as CFO
Stem cell therapeutic company Osiris Therapeutics Inc. (Nasdaq:OSIR) said before today’s opening that Richard W. Hunt had filled the chief financial officer spot effective July 23. The Columbia, Md.-based company also said it had promoted Philip R. Jacoby Jr. to vice president of finance.
In today’s trading, shares are mostly flat from Friday’s close of $15.46. Shares have ranged from $9.98 to $15.60.
In today’s trading, shares are mostly flat from Friday’s close of $15.46. Shares have ranged from $9.98 to $15.60.
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
